128 related articles for article (PubMed ID: 33309946)
1. On selecting the critical boundary functions in group-sequential trials with two time-to-event outcomes.
Hamasaki T; Hung HMJ; Hsiao CF; Evans SR
Contemp Clin Trials; 2021 Feb; 101():106244. PubMed ID: 33309946
[TBL] [Abstract][Full Text] [Related]
2. Testing a primary and a secondary endpoint in a group sequential design.
Tamhane AC; Mehta CR; Liu L
Biometrics; 2010 Dec; 66(4):1174-84. PubMed ID: 20337631
[TBL] [Abstract][Full Text] [Related]
3. Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance.
Li H; Wang J; Luo X; Grechko J; Jennison C
Biom J; 2018 Sep; 60(5):893-902. PubMed ID: 29876964
[TBL] [Abstract][Full Text] [Related]
4. A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks.
Tamhane AC; Gou J; Jennison C; Mehta CR; Curto T
Biometrics; 2018 Mar; 74(1):40-48. PubMed ID: 28589692
[TBL] [Abstract][Full Text] [Related]
5. Group sequential Holm and Hochberg procedures.
Tamhane AC; Xi D; Gou J
Stat Med; 2021 Oct; 40(24):5333-5350. PubMed ID: 34636081
[TBL] [Abstract][Full Text] [Related]
6. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (I): unknown correlation between the endpoints.
Tamhane AC; Wu Y; Mehta CR
Stat Med; 2012 Aug; 31(19):2027-40. PubMed ID: 22729929
[TBL] [Abstract][Full Text] [Related]
7. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
Zhao Y; Grambsch PM; Neaton JD
Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
[TBL] [Abstract][Full Text] [Related]
8. Adjustment on the Type I Error Rate for a Clinical Trial Monitoring for both Intermediate and Primary Endpoints.
Halabi S
J Biom Biostat; 2012 May; 7():15. PubMed ID: 24466469
[TBL] [Abstract][Full Text] [Related]
9. Allocating recycled significance levels in group sequential procedures for multiple endpoints.
Xi D; Tamhane AC
Biom J; 2015 Jan; 57(1):90-107. PubMed ID: 25355702
[TBL] [Abstract][Full Text] [Related]
10. Over-ruling a group sequential boundary--a stopping rule versus a guideline.
Lan KK; Lachin JM; Bautista O
Stat Med; 2003 Nov; 22(21):3347-55. PubMed ID: 14566919
[TBL] [Abstract][Full Text] [Related]
11. The performance of the O'Brien-Fleming multiple testing procedure in the presence of intraclass correlation.
Lui KJ
Biometrics; 1994 Mar; 50(1):232-6. PubMed ID: 8086606
[TBL] [Abstract][Full Text] [Related]
12. Use of logrank tests and group sequential methods at fixed calendar times.
DeMets DL; Gail MH
Biometrics; 1985 Dec; 41(4):1039-44. PubMed ID: 4096915
[TBL] [Abstract][Full Text] [Related]
13. Online control of the False Discovery Rate in group-sequential platform trials.
Zehetmayer S; Posch M; Koenig F
Stat Methods Med Res; 2022 Dec; 31(12):2470-2485. PubMed ID: 36189481
[TBL] [Abstract][Full Text] [Related]
14. Monitoring pairwise comparisons in multi-armed clinical trials.
Follmann DA; Proschan MA; Geller NL
Biometrics; 1994 Jun; 50(2):325-36. PubMed ID: 8068834
[TBL] [Abstract][Full Text] [Related]
15. Alternatives to the standard Fleming, Harrington, and O'Brien futility boundary.
Anderson JR; High R
Clin Trials; 2011 Jun; 8(3):270-6. PubMed ID: 21441286
[TBL] [Abstract][Full Text] [Related]
16. Weighted multiple testing correction for correlated tests.
Xie C
Stat Med; 2012 Feb; 31(4):341-52. PubMed ID: 22114000
[TBL] [Abstract][Full Text] [Related]
17. Sequential methods and group sequential designs for comparative clinical trials.
Sébille V; Bellissant E
Fundam Clin Pharmacol; 2003 Oct; 17(5):505-16. PubMed ID: 14703713
[TBL] [Abstract][Full Text] [Related]
18. Implementation of group sequential logrank tests in a maximum duration trial.
Lan KK; Lachin JM
Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413
[TBL] [Abstract][Full Text] [Related]
19. Methods to adjust for multiple comparisons in the analysis and sample size calculation of randomised controlled trials with multiple primary outcomes.
Vickerstaff V; Omar RZ; Ambler G
BMC Med Res Methodol; 2019 Jun; 19(1):129. PubMed ID: 31226934
[TBL] [Abstract][Full Text] [Related]
20. Optimal weighted Bonferroni tests and their graphical extensions.
Xi D; Chen Y
Stat Med; 2024 Feb; 43(3):475-500. PubMed ID: 38073604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
